Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.495
+0.0050.09%
Volume:68.42M
Turnover:379.47M
Market Cap:102.66B
PE:36.17
High:5.620
Open:5.400
Low:5.400
Close:5.490
52wk High:8.442
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.98
T/O Rate:0.37%
Dividend:0.12
Dividend Rate:2.23%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.69
PE(LYR):36.17
PS:2.60

Loading ...

Sino Biopharmaceutical Stock Rallies 6.5% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 06

Hong Kong Market Midday Update: Hang Seng Index Gains 0.83%, Tech Index Up 1.16% with Broad Tech Sector Gains; Power Equipment Stocks Strong, PCB Concept Shares Slump; Kuaishou Surges Over 5%

Deep News
·
Jul 06

Biopharma Stocks Continue to Rally in Early Trading Session

Deep News
·
Jul 06

Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization

Stock News
·
Jul 06

Stock Track | SBP GROUP Soars 5.49% Intraday on Drug Pipeline Progress and Favorable Policy Support

Stock Track
·
Jul 06

Movement Alert|Sino Biopharmaceutical Rises 3.38% in Regular Trading, NDA Acceptance and Medical Insurance Policy Boost Sentiment

Market Focus
·
Jul 06

Sino Biopharma Unit's Application for Analgesic Accepted in China

MT Newswires Live
·
Jul 03

Sino Biopharm’s NDA for First-in-Class Long-Acting Ropivacaine Analgesic Accepted by China CDE

Bulletin Express
·
Jul 03

SBP GROUP's New Painkiller Application Accepted for Review

Stock News
·
Jul 03

Sino Biopharmaceutical - China's Cde Accepts New Drug Application for Ropivacaine Hydrochloride Sustained-release Solution

THOMSON REUTERS
·
Jul 03

Sino Biopharmaceutical Stock Climbs 2.6% in Hong Kong

Dow Jones
·
Jul 03

Movement Alert|Sino Biopharmaceutical Rises 4.76% in Regular Trading, National Medical Insurance Catalog Adjustment Favors Innovative Drug Companies

Market Focus
·
Jul 03

Stock Track | SBP GROUP Soars 5.19% Intraday on Regulatory Approvals for Drug Pipeline

Stock Track
·
Jul 03

Sino Biopharmaceutical (SEHK:1177) Advances Pipeline As Valuation Signals Stay Mixed

Simply Wall St.
·
Jul 03

Sino Biopharmaceutical Stock Advances 4.8% in Hong Kong

Dow Jones
·
Jul 02

Sino Biopharm trims outstanding shares by 40.35 million in June, confirms public-float compliance

Bulletin Express
·
Jul 02

Stock Track | SBP GROUP Soars 7.26% Intraday on Strategic AI Investment, Drug Approvals and Sector Rally

Stock Track
·
Jul 02

Movement Alert|Sino Biopharmaceutical Rises 4.99% in Regular Trading, Pharmaceutical Sector Rally Combined with Strategic AI Investment

Market Focus
·
Jul 02

Sino Biopharmaceutical Stock Rises 5.4% in Hong Kong

Dow Jones
·
Jun 29

Stock Track | SBP GROUP Soars 5.63% Intraday on Buyback Plan, Pipeline Milestones, and Sector Rally

Stock Track
·
Jun 29